Jefferies Financial Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-103,200
Closed -$1.59M 1853
2025
Q4
$1.59M Sell
103,200
-65,400
-39% -$720K 0.01% 895
2025
Q3
$1.67M Buy
+168,600
New +$1.75M 0.01% 705
2025
Q2
Sell
-46,800
Closed -$607K 1426
2025
Q1
$607K Sell
46,800
-145,974
-76% -$1.93M 0.01% 992
2024
Q4
$2.46M Buy
+192,774
New +$2.33M 0.01% 598
2024
Q1
Sell
-94,600
Closed -$1.32M 1708
2023
Q4
$1.32M Sell
94,600
-101,100
-52% -$1.4M 0.01% 855
2023
Q3
$2.89M Buy
195,700
+150,000
+328% +$2.11M 0.03% 500
2023
Q2
$590K Buy
+45,700
New +$521K 0.01% 1125
2023
Q1
Sell
-6,730
Closed -$71.6K 1712
2022
Q4
$71.6K Buy
+6,730
New +$78.2K ﹤0.01% 1388

Other funds holding DVAX

Jefferies Financial Group's DVAX Position: Q1 2026 in Review

Jefferies Financial Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 103,200 shares — an estimated $1.59M sold.

Jefferies Financial Group first reported a position in DVAX in Q4 2022 and held it in 8 quarters. The position peaked at $2.89M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Jefferies Financial Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 103,200 Dynavax Technologies shares in Q1 2026, an estimated $1.59M.
  • Jefferies Financial Group first reported a position in Dynavax Technologies in Q4 2022 and held it in 8 quarters.
  • Jefferies Financial Group's Dynavax Technologies position peaked at $2.89M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.